CBLL
CeriBell, Inc.
CBLL lost money over the past year, so it has no meaningful PE right now.
CBLL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
CBLL's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CBLL PE Valuation
CBLL has no meaningful PE right now: it lost money over the past year.
CBLL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CBLL's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
CBLL Earnings Per Share
CBLL is still losing money, but less than at its worst: $1.93 per share over the past year, against $2.71 at its worst in late 2024.
CBLL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $29.3M | +30% |
| Q2 2026 | $28.1M | +33% |
| Q1 2026 | $26.5M | +29% |
| Q4 2025 | $24.8M | +34% |
| Q3 2025 | $22.6M | +31% |
| Q2 2025 | $21.2M | +43% |
| Q1 2025 | $20.5M | +38% |
| Q4 2024 | $18.5M | +41% |
CBLL's revenue has grown year over year every quarter since early 2024: $29M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -70% | -5.2 points |
| Q2 2026 | -71% | -0.6 points |
| Q1 2026 | -78% | -9 points |
| Q4 2025 | -59% | +11 points |
| Q3 2025 | -65% | -7.1 points |
| Q2 2025 | -71% | -14 points |
| Q1 2025 | -69% | -13 points |
| Q4 2024 | -70% | -5.7 points |
CBLL's operating margin was −70% last quarter, down 5.2 points from the same quarter a year ago.
CBLL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$13.2M | -$1.7M |
| Q2 2026 | -$12.9M | -$5.3M |
| Q1 2026 | -$19.4M | -$7.9M |
| Q4 2025 | -$11M | -$621K |
| Q2 2025 | -$7.6M | -$344K |
| Q1 2025 | -$11.6M | -$1.9M |
| Q4 2024 | -$10.3M | -$3M |
| Q2 2024 | -$7.3M | +$963K |
CBLL has burned cash in almost every quarter: −$56M over the past year, against −$41M the year before.
CBLL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +468K shares |
| 1 year | +4.6% | +1.7M shares |
| 3 years | +65% | +15.2M shares |
CBLL has 39M diluted shares, up 4.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
CBLL Net Leverage
CBLL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CBLL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 80.0 | Neutral |
CBLL's weekly RSI is 65 (neutral) and its Stochastic is 80 (neutral).
CBLL PE vs Healthcare Sector
CBLL has no meaningful PE right now: it lost money over the past year.
CBLL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.3 | 4% above |
| 20 week MA | $22.9 | 15% above |
| 50 week MA | $21.0 | 25% above |
| 100 week MA | $19.0 | 38% above |
CBLL is in an uptrend: it's above all four of its weekly moving averages, and 38% above its 100-week average.
CBLL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $25.0 | $26.5 | +5.8% |
| 2025 | $26.5 | $21.3 | -19% |
| 2026 YTD | $21.3 | $26.4 | +24% |
CBLL has finished lower in one of the last two years. It's up 24% so far in 2026.